BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10978581)

  • 1. Dopaminergic neurotoxins, 6,7-dihydroxy-1-(3', 4'-dihydroxybenzyl)-isoquinolines, cause different types of cell death in SH-SY5Y cells: apoptosis was induced by oxidized papaverolines and necrosis by reduced tetrahydropapaverolines.
    Maruyama W; Sango K; Iwasa K; Minami C; Dostert P; Kawai M; Moriyasu M; Naoi M
    Neurosci Lett; 2000 Sep; 291(2):89-92. PubMed ID: 10978581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An endogenous dopaminergic neurotoxin, N-methyl-(R)-salsolinol, induces DNA damage in human dopaminergic neuroblastoma SH-SY5Y cells.
    Maruyama W; Naoi M; Kasamatsu T; Hashizume Y; Takahashi T; Kohda K; Dostert P
    J Neurochem; 1997 Jul; 69(1):322-9. PubMed ID: 9202326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A neurotoxin N-methyl(R)salsolinol induces apoptotic cell death in differentiated human dopaminergic neuroblastoma SH-SY5Y cells.
    Maruyama W; Benedetti MS; Takahashi T; Naoi M
    Neurosci Lett; 1997 Sep; 232(3):147-50. PubMed ID: 9310301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective function of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane, [R-(-)-BPAP], against apoptosis induced by N-methyl(R)salsolinol, an endogenous dopaminergic neurotoxin, in human dopaminergic neuroblastoma SH-SY5Y cells.
    Maruyama W; Yi H; Takahashi T; Shimazu S; Ohde H; Yoneda F; Iwasa K; Naoi M
    Life Sci; 2004 May; 75(1):107-17. PubMed ID: 15102525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidation of N-methyl(R)salsolinol: involvement to neurotoxicity and neuroprotection by endogenous catechol isoquinolines.
    Naoi M; Maruyama W; Kasamatsu T; Dostert P
    J Neural Transm Suppl; 1998; 52():125-38. PubMed ID: 9564615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isatin, an endogenous monoamine oxidase inhibitor, triggers a dose- and time-dependent switch from apoptosis to necrosis in human neuroblastoma cells.
    Igosheva N; Lorz C; O'Conner E; Glover V; Mehmet H
    Neurochem Int; 2005 Aug; 47(3):216-24. PubMed ID: 15876476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopamine neurons.
    Naoi M; Maruyama W; Akao Y; Zhang J; Parvez H
    Toxicology; 2000 Nov; 153(1-3):123-41. PubMed ID: 11090952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron contributes to the formation of catechol isoquinolines and oxidative toxicity induced by overdose dopamine in dopaminergic SH-SY5Y cells.
    Wang R; Qing H; Liu XQ; Zheng XL; Deng YL
    Neurosci Bull; 2008 Jun; 24(3):125-32. PubMed ID: 18500384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of reactive oxygen species accounts for cytotoxicity of an endogenous dopaminergic neurotoxin, (R)-N-methylsalsolinol, to differentiated dopaminergic SH-SY5Y cells.
    Minami C; Deng Y; Maruyama W; Takahashi T; Kawai M; Nakahara D; Naoi M
    J Neural Transm (Vienna); 1998; 105(4-5):397-405. PubMed ID: 9720969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake of a neurotoxin-candidate, (R)-1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline into human dopaminergic neuroblastoma SH-SY5Y cells by dopamine transport system.
    Takahashi T; Deng Y; Maruyama W; Dostert P; Kawai M; Naoi M
    J Neural Transm Gen Sect; 1994; 98(2):107-18. PubMed ID: 7734108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity of endogenous isoquinolines to human dopaminergic neuroblastoma SH-SY5Y cells.
    Takahashi T; Maruyama W; Deng Y; Dostert P; Nakahara D; Niwa T; Ohta S; Naoi M
    J Neural Transm (Vienna); 1997; 104(1):59-66. PubMed ID: 9085193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell death of dopamine neurons in aging and Parkinson's disease.
    Naoi M; Maruyama W
    Mech Ageing Dev; 1999 Nov; 111(2-3):175-88. PubMed ID: 10656535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiapoptotic effects of nicotine in its protection against salsolinol-induced cytotoxicity.
    Copeland RL; Das JR; Kanaan YM; Taylor RE; Tizabi Y
    Neurotox Res; 2007 Jul; 12(1):61-9. PubMed ID: 17513200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRPC1 protects dopaminergic SH-SY5Y cells from MPP+, salsolinol, and N-methyl-(R)-salsolinol-induced cytotoxicity.
    Arshad A; Chen X; Cong Z; Qing H; Deng Y
    Acta Biochim Biophys Sin (Shanghai); 2014 Jan; 46(1):22-30. PubMed ID: 24252728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRPC1 protects human SH-SY5Y cells against salsolinol-induced cytotoxicity by inhibiting apoptosis.
    Bollimuntha S; Ebadi M; Singh BB
    Brain Res; 2006 Jul; 1099(1):141-9. PubMed ID: 16765919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulated expression of secretogranin III is involved in neurotoxin-induced dopaminergic neuron apoptosis.
    Li F; Tian X; Zhou Y; Zhu L; Wang B; Ding M; Pang H
    J Neurosci Res; 2012 Dec; 90(12):2237-46. PubMed ID: 22987761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norharman, an indoleamine-derived beta-carboline, but not Trp-P-2, a gamma-carboline, induces apoptotic cell death in human neuroblastoma SH-SY5Y cells.
    Uezono T; Maruyama W; Matsubara K; Naoi M; Shimizu K; Saito O; Ogawa K; Mizukami H; Hayase N; Shiono H
    J Neural Transm (Vienna); 2001; 108(8-9):943-53. PubMed ID: 11716147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease.
    Xie HR; Hu LS; Li GY
    Chin Med J (Engl); 2010 Apr; 123(8):1086-92. PubMed ID: 20497720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptotic cell death in differentiating neuroblastoma SH-SY5Y cells by colchicine.
    Nakagawa-Yagi Y
    Biochem Biophys Res Commun; 1994 Mar; 199(2):807-17. PubMed ID: 8135827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter.
    Storch A; Ott S; Hwang YI; Ortmann R; Hein A; Frenzel S; Matsubara K; Ohta S; Wolf HU; Schwarz J
    Biochem Pharmacol; 2002 Mar; 63(5):909-20. PubMed ID: 11911843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.